ZOETIS INC. (ZTS) is a publicly traded Healthcare sector company. As of August 19, 2026, ZTS trades at $74.20 with a market cap of $30.15B and a P/E ratio of 12.23. ZTS moved +1.80% today. Year to date, ZTS is -41.22%; over the trailing twelve months it is -51.44%. Its 52-week range spans $71.00 to $177.40. Analyst consensus is buy with an average price target of $91.67. Rallies surfaces ZTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ZTS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ZTS recently traded at $74.20. Market cap is $30.15B. P/E ratio is 12.23. Revenue is $9.52B.
| Metric | Value |
|---|---|
| Price | $74.20 |
| Market Cap | $30.15B |
| P/E Ratio | 12.23 |
| EPS | $6.08 |
| Dividend Yield | 0.53% |
| 52-Week High | $177.40 |
| 52-Week Low | $71.00 |
| Volume | 3.27M |
| Avg Volume | 0 |
| Revenue (TTM) | $9.52B |
| Net Income | $2.62B |
| Gross Margin | 71.53% |
12 analysts cover ZTS: 0 strong buy, 5 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $91.67.